Stocks News

LAST PRICE
29.5200
TODAY'S CHANGE (%)
Trending Down-0.2900 (-0.9728%)

Bid / Lots
28.5000/ 2
Ask / Lots
30.2000/ 1
Open / Previous Close
30.0200 / 29.8100
Day Range
Low 29.2500
High 30.5000
52 Week Range
Low 16.9650
High 35.8400
Volume
273,346
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 20, 2024
- Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
  7:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: CSTL
  
  Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference
  FRIENDSWOOD, Texas--(BUSINESS WIRE)--November 20, 2024--
  Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Piper Sandler 36(th) Annual Healthcare Conference on Wednesday, Dec. 4, 2024, at 10:50 a.m. Eastern time.
Nov 19, 2024
- Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year, from 7:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  7:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: CSTL
  
  Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year
  
  Castle also earns national recognition through three additional Top Workplaces Culture Excellence Awards -- Employee Appreciation, Employee Well-Being and Professional Development
Nov 8, 2024
- Castle Biosciences to Present New Data Highlighting the Clinical Performance of DecisionDx(R)-Melanoma and MyPath(R) Melanoma at the American Society of Dermatopathology 61st Annual Meeting, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones
  7:00AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: CSTL
  
  Castle Biosciences to Present New Data Highlighting the Clinical Performance of DecisionDx(R)-Melanoma and MyPath(R) Melanoma at the American Society of Dermatopathology 61st Annual Meeting
Nov 7, 2024
- Castle Biosciences Surpasses 25,000 Test Reports Delivered for its TissueCypher(R) Barrett's Esophagus Test, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: CSTL
  
  Castle Biosciences Surpasses 25,000 Test Reports Delivered for its TissueCypher(R) Barrett's Esophagus Test
  
  TissueCypher is Castle's precision medicine risk-stratification test that predicts a patient's individual risk of progression from Barrett's esophagus (BE) to esophageal cancer
Nov 6, 2024
- DJ Castle Biosciences Is Maintained at Sector Outperform by Scotiabank, from 11:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  11:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: CSTL
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/CSTL/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 06, 2024 11:00 ET (16:00 GMT)

Yesterday
- Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 29, 2024 in Paragon 28, Inc. Lawsuit - FNA, from 7 hours ago by Accesswire
  7 hours ago by Accesswire
  Companies Mentioned: FNA
- Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 29, 2024 in Paragon 28, Inc. Lawsuit - FNA, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: FNA
- SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Paragon 28, Inc. - FNA, from 8 hours ago by PR Newswire
  8 hours ago by PR Newswire
  Companies Mentioned: FNA
- SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Paragon 28, Inc. - FNA, from 8 hours ago by Dow Jones
  8 hours ago by Dow Jones
  Companies Mentioned: FNA
- Class Action Filed Against Paragon 28, Inc. (FNA) - November 29, 2024 Deadline to Join - Contact Levi & Korsinsky, from 10 hours ago by Accesswire
  10 hours ago by Accesswire
  Companies Mentioned: FNA
- Class Action Filed Against Paragon 28, Inc. (FNA) - November 29, 2024 Deadline to Join - Contact Levi & Korsinsky, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: FNA
- DEADLINE ALERT for BMBL, MGX, POWW, FNA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders, from 11 hours ago by Dow Jones
  11 hours ago by Dow Jones
  Companies Mentioned: POWW, BMBL, FNA, MGX
- Levi & Korsinsky Reminds Paragon 28, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 29, 2024 - FNA, from 11 hours ago by Accesswire
  11 hours ago by Accesswire
  Companies Mentioned: FNA
- Levi & Korsinsky Reminds Paragon 28, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 29, 2024 - FNA, from 11 hours ago by Dow Jones
  11 hours ago by Dow Jones
  Companies Mentioned: FNA
- Paragon 28, Inc. Is Being Sued For Violating Securities Regulations And The Schall Law Firm Invites Investor Participation, from 12 hours ago by Accesswire
  12 hours ago by Accesswire
  Companies Mentioned: FNA

Castle Biosciences Inc
NASDAQ:CSTLUnited States

Search Criteria

Nov 20, 2024

Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 19, 2024

Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year, from 7:00AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 8, 2024

Castle Biosciences to Present New Data Highlighting the Clinical Performance of DecisionDx(R)-Melanoma and MyPath(R) Melanoma at the American Society of Dermatopathology 61st Annual Meeting, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 7, 2024

Castle Biosciences Surpasses 25,000 Test Reports Delivered for its TissueCypher(R) Barrett's Esophagus Test, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 6, 2024

DJ Castle Biosciences Is Maintained at Sector Outperform by Scotiabank, from 11:00AM ET on Wednesday Nov 06, 2024 by Dow Jones

Peers Headlines

Yesterday

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 29, 2024 in Paragon 28, Inc. Lawsuit - FNA, from 7 hours ago by Accesswire

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 29, 2024 in Paragon 28, Inc. Lawsuit - FNA, from 7 hours ago by Dow Jones

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Paragon 28, Inc. - FNA, from 8 hours ago by PR Newswire

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Paragon 28, Inc. - FNA, from 8 hours ago by Dow Jones

Class Action Filed Against Paragon 28, Inc. (FNA) - November 29, 2024 Deadline to Join - Contact Levi & Korsinsky, from 10 hours ago by Accesswire

Class Action Filed Against Paragon 28, Inc. (FNA) - November 29, 2024 Deadline to Join - Contact Levi & Korsinsky, from 10 hours ago by Dow Jones

DEADLINE ALERT for BMBL, MGX, POWW, FNA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders, from 11 hours ago by Dow Jones

Levi & Korsinsky Reminds Paragon 28, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 29, 2024 - FNA, from 11 hours ago by Accesswire

Levi & Korsinsky Reminds Paragon 28, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 29, 2024 - FNA, from 11 hours ago by Dow Jones

Paragon 28, Inc. Is Being Sued For Violating Securities Regulations And The Schall Law Firm Invites Investor Participation, from 12 hours ago by Accesswire